semaglutide api market GLP-1 Receptor Agonist Growth Analysis How Asian pharma suppliers cash

Securing the first and fastest Tentative ANDA Approval globally for Generic Ozempic (Semaglutide Injection) in partnership with Apotex Inc

Clinically Tested Performance

Will GLP-1s remain dominant, or will new innovations emerge

18% of US adults have tried a GLP-1 drug to lose weight or to treat diabetes or heart disease, and 12% are currently using them, per new KFF survey data

Zamzam Family Clinic offers medical programs, GLP-1 therapy, and doctor supervised weight loss plans

While we provide access to the most effective GLP-1 peptides like semaglutide and tirzepatide, we recognize that long-term success requires treating the whole person.